In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Cicloplegicedol Drug Master File in Korea (Cicloplegicedol KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Cicloplegicedol. The MFDS reviews the Cicloplegicedol KDMF as part of the drug registration process and uses the information provided in the Cicloplegicedol KDMF to evaluate the safety and efficacy of the drug.
After submitting a Cicloplegicedol KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Cicloplegicedol API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Cicloplegicedol suppliers with KDMF on PharmaCompass.